Not everyone faces the same cancer risk, and personal circumstances should guide the approach to any substance with theoretical oncological concerns
Design of engineered GLP-1 albumin fusions with favorable FcRn binding properties The FDA-approved GLP-1 RA, Tanzeum (albiglutide), consists of two repeats of the DDP-4-resistant GLP-1 (residues 736) peptide fused in tandem to the N-terminal end of human albumin (Fig
Beyond weight loss, these medications are game-changers for managing type 2 diabetes
Semaglutides effects extend to decreasing the risk of heart failure, heart attacks, and other major cardiovascular problems by also reducing the inflammation that can damage blood vessels
That is almost a 50-fold difference in total weekly intake for what is, fundamentally, the same drug, simply because most of the substance is degraded before they can be absorbed into the blood